ArticleJournal of gastrointestinal oncology2024

Immune checkpoint inhibitors combined with paclitaxel-based chemotherapy versus chemotherapy alone as first-line treatment in HER2-negative advanced gastric cancer: result of a multicenter retrospective study.

Yulu Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.